Staff

Dawn has been a leader in the bleeding disorders community for many years.  As a parent of a son with hemophilia, she founded the Rocky Mountain Hemophilia & Bleeding Disorders Association in Bozeman, Montana, served as its Executive Director, and began their Family Camp. After moving to Pittsburgh, Pennsylvania, Dawn worked for the American Diabetes Association (ADA) as an Area Manager. Concurrently, she served as a board member for the Hemophilia Center of Western Pennsylvania for six years. Dawn left the ADA for a position as the Executive Director of the Western Pennsylvania Chapter of the NHF in Pittsburgh, where she became actively involved with Camp Hot to Clot and eventually became the Director. She holds a Bachelor of Science from Montana State University in Bozeman.

Dr. Michael Recht entered the role of Chief Medical and Scientific Officer at the foundation in early 2023.

Prior to this role, he served as the Chief Science Officer (CSO) of the American Thrombosis and Hemostasis Network (ATHN).  As ATHN's CSO, Dr. Recht worked at the strategic and policy level to inform the scientific direction of the organization. 

In addition to his role as ATHN's CSO, Dr. Recht, a pediatric hematologist and Professor of Clinical Pediatrics at Yale University School of Medicine, sees children and young adults affected by non-malignant blood conditions, particularly bleeding and clotting disorders. As a member of the Division of Pediatric Hematology/Oncology, he contributes to the care of children with blood disorders at Yale New Haven Children's Hospital.

Before assuming his role as ATHN's CSO, Dr. Recht was previously the director of the Hemophilia Center at Oregon Health & Science University in Portland, OR as well as the director of the Mountain States Hemophilia Network, the federally-supported collaboration of Hemophilia Treatment Centers in the states of Alaska, Arizona, Colorado, Idaho, Montana, New Mexico, Oregon, Utah, Washington and Wyoming.

Dr. Recht has actively participated in over 110 clinical research trials testing new treatments for children with bleeding and clotting disorders, including being a leader in research involving gene therapy for hemophilia.

Peter Harvey serves as the Chief Business Officer for NHF including oversight for finance & accounting, business development, conference & travel services, payer relations, and IT. Peter is a senior healthcare finance and operations executive with diverse experience in healthcare nonprofit finance & accounting, pharma/biotech HEOR and medical affairs business operations, academic medical/pediatric department and Hemophilia Treatment Center administration, plus PM&R medical practice and research foundation executive leadership. Peter has volunteered at a number of non-profits and is a founding volunteer board member of a nonprofit providing education and humanitarian support to children and families in Mariani, Haiti. He has a B.A. in Biology from Augustana College and a M.B.A. from the University of Chicago, Booth School of Business in Finance and Healthcare.